{"doi":"10.1093/jnci/djv133","title":"Detecting Overall Survival Benefit Derived From Survival Postprogression Rather Than Progression-Free Survival","abstract":null,"journal":"JNCI: Journal of the National Cancer Institute","year":2015,"id":18673,"datarank":2.2446429873611087,"base_score":3.6888794541139363,"endowment":3.6888794541139363,"self_citation_contribution":0.5533319181170905,"citation_network_contribution":1.6913110692440183,"self_endowment_contribution":0.5533319181170905,"citer_contribution":1.6913110692440183,"corpus_percentile":null,"corpus_rank":null,"citation_count":39,"citer_count":31,"citers_with_citation_signal":24,"citers_with_endowment":24,"datacite_reuse_total":10,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":128948,"name":"Kentaro Sakamaki","orcid":null,"position":1,"is_corresponding":false},{"id":128949,"name":"Guosheng Yin","orcid":null,"position":2,"is_corresponding":false},{"id":128947,"name":"Satoshi Morita","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.6888794541139363,"endowment":3.6888794541139363,"datacite_reuse_total":10,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25956357","pmcid":"PMC4609552","openalex_id":"https://openalex.org/W1912259233","authors":[],"funders":[],"total_grants":0,"fwci":1.5875,"citation_percentile":0.845906,"influential_citations":0,"citation_trend":[{"year":2015,"count":1},{"year":2016,"count":6},{"year":2017,"count":1},{"year":2018,"count":3},{"year":2019,"count":2},{"year":2020,"count":4},{"year":2021,"count":5},{"year":2022,"count":4},{"year":2023,"count":8},{"year":2024,"count":2},{"year":2026,"count":3}],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://academic.oup.com/jnci/article-pdf/107/8/djv133/17314803/djv133.pdf","host_type":"journal"},{"url":"https://academic.oup.com/jnci/article-pdf/107/8/djv133/17314803/djv133.pdf","host_type":"BRONZE"},{"url":"https://academic.oup.com/jnci/article-pdf/107/8/djv133/17314803/djv133.pdf","host_type":"publisher"},{"url":"http://academic.oup.com/jnci/article-pdf/107/8/djv133/17314803/djv133.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1093/jnci/djv133","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25956357","host_type":"repository"},{"url":"http://hdl.handle.net/10722/217216","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4609552","host_type":"repository"}],"fields_of_study":["Colorectal Cancer Treatments and Studies","Cancer Treatment and Pharmacology","Cancer Genomics and Diagnostics","Medicine","Antineoplastic Agents","Clinical Trials as Topic","Disease-Free Survival","Humans","Kaplan-Meier Estimate","Neoplasms","Odds Ratio"],"mesh_terms":["Antineoplastic Agents","Clinical Trials as Topic","Humans","Neoplasms","Odds Ratio","Disease-Free Survival","Kaplan-Meier Estimate"],"keywords":["Overall survival","Oncology","Progression-free survival","Clinical endpoint","Internal medicine","Medicine","Clinical trial","Counterintuitive","Statistical significance","Treatment effect","Survival analysis"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.22614634.v1","title":"Additional file 1 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614634","title":"Additional file 1 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614637.v1","title":"Additional file 2 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614637","title":"Additional file 2 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614640.v1","title":"Additional file 3 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614640","title":"Additional file 3 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614643.v1","title":"Additional file 4 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614643","title":"Additional file 4 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614646.v1","title":"Additional file 5 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22614646","title":"Additional file 5 of Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-03T23:07:17.343417Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}